NICE recommends four treatments for arthritis in children
October 22, 2015Medical Communications, Research and Development NICE, arthritis, jia
UK Healthcare guidance body NICE has today published final draft guidance recommending four drugs for the treatment of juvenile ideopathic …
UK and China sign £2 billion in healthcare trade and investment deals
October 22, 2015Research and Development
More than £2 billion of healthcare trade deals and collaborations have been signed between Chinese and UK companies, universities, and …
Physicians Interactive acquires Univadis portal
October 22, 2015Medical Communications, Sales and Marketing Merck, Physicians Interactive, Univadis
Digital marketing firm Physicians Interactive (PI) has acquired the Univadis medical information platform, in a move which it says creates …
Executive vice president Tony Kingsley leaves Biogen
October 22, 2015Biogen, John Cox, Tony Kingsley
Biogen has begun the search for a replacement for Tony Kingsley, former executive vice president of global commercial operations.Kingsley will …
Roche buoyed by 6% sales growth
October 22, 2015Sales and Marketing Roche, financial results
Roche has reported strong sales growth for the first nine months of 2015 and revised its sales outlook to reflect …
World’s largest clinical trial of aspirin in cancer launches in UK
October 22, 2015Research and Development CRUK, Cancer, Cancer Research UK, aspirin, clinical trial, phase III
The world’s largest ever clinical trial has been launched across the UK today, to discover whether taking aspirin every day …
Revenues up at Biogen – but job losses planned
October 22, 2015Biogen, financial results, job losses, redundancies
Despite lower than predicted sales of its top-selling products, Biogen has achieved $2.8 billion in revenues in the third quarter …
Biogen’s natalizumab fails Phase III endpoints
October 21, 2015Biogen, multiple sclerosis
Biogen’s natalizumab has failed to achieve clinical endpoints in a late-stage study to prove the drug’s potential in patients with …
Encouraging late-stage results for Stelara in Crohn’s disease
October 21, 2015Research and Development, Sales and Marketing Crohn’s disease, Janssen, Stelera, crohn's disease, ustekinumab
Janssen is planning new regulatory submissions for Stelera after Phase III data found it improved responses and remission rates in …
DNA expands in London, appointing Heather Grant to lead new division
October 21, 2015Medical Communications
DNA’s well-established medical communications practice will now offer fully integrated healthcare communications to its clients. Neil Flash remains DNA’s managing …
DNA expands in London, appointing Heather Grant to lead new division
October 21, 2015Medical Communications
DNA’s well-established medical communications practice will now offer fully integrated healthcare communications to its clients. Neil Flash remains DNA’s managing …
Featured Market Report – Kidney Disease Global Clinical Trials Review
October 21, 2015Research and Development
GlobalData’s “Kidney Disease Global Clinical Trials Review, H2, 2015″ gives invaluable insight into the current state of clinical trials in …
Global warning for governments to step up R&D spending
October 21, 2015Research and Development
Countries should step up their investment in long-term R&D to develop disruptive technologies that will reshape industry, healthcare and communications, …
NICE issues draft guidance for MSD’s Ezetrol
October 21, 2015Sales and Marketing MSD, NICE, cardiovascular disease, ezetimibie, ezetrol, high cholesterol
NICE has published draft guidance recommending MSD’s Ezetrol as an option for some adults with high cholesterol. The guidance updates …
Future Focus: The industry’s top five biggest drug patent expirations in 2016
October 21, 2015Manufacturing and Production, Research and Development biosimilars, blockbuster, generics, patent cliff, patents
From Humira to Cubicin, some multi-billion dollar drugs are set to be hit hard by patent expiries next year, and …
Novartis acquires Admune Therapeutics
October 21, 2015Research and Development Admune Therapeutics, Cancer, Novartis, Palobiofarma, immunotherapy
Novartis is broadening its portfolio of cancer immunotherapies with the acquisition of Admune Therapeutics, and signing licensing agreements with Palobiofarma …
NHS research activity on the rise
October 21, 2015Research and Development
NHS England has achieved a significant increase in clinical research over the last year, according to new data from The …
Valeant announces strong Q3 results, will expand US contact lens plant
October 20, 2015Manufacturing and Production, Sales and Marketing Valeant, financial results, manufacturing, production
Valeant has announced plans to invest up to $150 million and add 200 jobs at its Bausch and Lomb plant …
‘Female Viagra’ goes on sale in the US
October 20, 2015Addyi, HSDD, Sprout, female viagra, flibanserin, hypoactive sexual desire disorder
The pill dubbed the female version of Viagra – Sprout Pharmaceuticals’ Addyi – has gone on sale in the US. …
Daiichi sheds more US jobs as generic losses take their toll
October 20, 2015Daiichi, Daiichi Sankyo, generic competition, generics, job losses, patent cliff, patents, redundancies
The Japan-based drugmaker Daiichi Sankyo is to cut up to 1,200 jobs – or about half its workforce – in …
Latest content
Global coalition calls for stronger government action on COPD
Global health researchers call for more equitable partnerships
Liverpool launches £20m lab for infectious disease drug discovery
Circle Health Group expands into UK laboratory operations
FibroFind appoints Professor Andrew Fisher as Chief Medical Officer
